NMTR Annual Operating Profit
-$42.02 M
-$10.36 M-32.72%
31 December 2022
Summary:
As of February 5, 2025, NMTR annual operaing income is -$42.02 million, with the most recent change of -$10.36 million (-32.72%) on December 31, 2022. During the last 3 years, it has fallen by -$17.73 million (-73.03%).NMTR Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMTR Quarterly Operating Profit
-$12.79 M
-$2.05 M-19.05%
31 March 2023
Summary:
As of February 5, 2025, NMTR quarterly operating income is -$12.79 million, with the most recent change of -$2.05 million (-19.05%) on March 31, 2023. Over the past year, it has dropped by -$1.42 million (-12.52%).NMTR Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMTR TTM Operating Profit
-$43.44 M
-$1.42 M-3.39%
31 March 2023
Summary:
As of February 5, 2025, NMTR TTM operating income is -$43.44 million, with the most recent change of -$1.42 million (-3.39%) on March 31, 2023. Over the past year, it has dropped by -$5.82 million (-15.46%).NMTR TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMTR Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -32.7% | -12.5% | -15.5% |
| 3 y3 years | -73.0% | -199.6% | -79.2% |
| 5 y5 years | -276.2% | -12.9% | -78.9% |
NMTR Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +1148.7% | -5920.4% | +3651.3% |
9 Meters Biopharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$12.79 M(+19.0%) | -$43.44 M(+3.4%) |
| Dec 2022 | -$42.02 M(+32.7%) | -$10.74 M(+23.2%) | -$42.02 M(+2.9%) |
| Sept 2022 | - | -$8.72 M(-22.1%) | -$40.84 M(+0.7%) |
| June 2022 | - | -$11.20 M(-1.5%) | -$40.56 M(+7.8%) |
| Mar 2022 | - | -$11.36 M(+18.8%) | -$37.62 M(+18.8%) |
| Dec 2021 | -$31.66 M(+47.6%) | -$9.56 M(+13.4%) | -$31.66 M(+17.8%) |
| Sept 2021 | - | -$8.44 M(+2.1%) | -$26.87 M(+8.6%) |
| June 2021 | - | -$8.26 M(+53.0%) | -$24.74 M(+9.5%) |
| Mar 2021 | - | -$5.40 M(+13.1%) | -$22.58 M(+5.3%) |
| Dec 2020 | -$21.45 M(-11.7%) | -$4.78 M(-24.3%) | -$21.45 M(-10.7%) |
| Sept 2020 | - | -$6.30 M(+3.3%) | -$24.02 M(-0.8%) |
| June 2020 | - | -$6.10 M(+43.0%) | -$24.22 M(-0.1%) |
| Mar 2020 | - | -$4.27 M(-41.8%) | -$24.24 M(-0.2%) |
| Dec 2019 | -$24.28 M(+33.2%) | -$7.34 M(+12.8%) | -$24.28 M(+17.4%) |
| Sept 2019 | - | -$6.51 M(+6.3%) | -$20.68 M(+48.2%) |
| June 2019 | - | -$6.12 M(+42.0%) | -$13.96 M(+24.5%) |
| Mar 2019 | - | -$4.31 M(+15.3%) | -$11.21 M(-38.5%) |
| Dec 2018 | -$18.22 M | -$3.74 M(-1801.9%) | -$18.22 M(+9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $219.70 K(-106.5%) | -$16.71 M(-13.3%) |
| June 2018 | - | -$3.38 M(-70.2%) | -$19.27 M(+3.7%) |
| Mar 2018 | - | -$11.33 M(+409.9%) | -$18.58 M(+66.4%) |
| Dec 2017 | -$11.17 M(+87.9%) | -$2.22 M(-5.1%) | -$11.17 M(+9.6%) |
| Sept 2017 | - | -$2.34 M(-13.0%) | -$10.19 M(-0.2%) |
| June 2017 | - | -$2.69 M(-31.3%) | -$10.22 M(+21.2%) |
| Mar 2017 | - | -$3.92 M(+214.6%) | -$8.43 M(+37.3%) |
| Dec 2016 | -$5.94 M(-8.0%) | -$1.25 M(-47.3%) | -$6.14 M(-14.9%) |
| Sept 2016 | - | -$2.36 M(+162.4%) | -$7.21 M(+15.6%) |
| June 2016 | - | -$901.00 K(-44.7%) | -$6.24 M(-2.4%) |
| Mar 2016 | - | -$1.63 M(-29.8%) | -$6.40 M(-1.0%) |
| Dec 2015 | -$6.46 M(-3.2%) | -$2.32 M(+66.6%) | -$6.46 M(-24.6%) |
| Sept 2015 | - | -$1.39 M(+31.7%) | -$8.56 M(+2.8%) |
| June 2015 | - | -$1.06 M(-37.5%) | -$8.33 M(+14.5%) |
| Mar 2015 | - | -$1.69 M(-61.7%) | -$7.27 M(+30.3%) |
| Dec 2014 | -$6.68 M(+98.4%) | -$4.42 M(+281.9%) | -$5.58 M(+381.9%) |
| Sept 2014 | - | -$1.16 M | -$1.16 M |
| Dec 2013 | -$3.37 M | - | - |
FAQ
- What is 9 Meters Biopharma annual operaing income?
- What is the all time high annual operating profit for 9 Meters Biopharma?
- What is 9 Meters Biopharma annual operating profit year-on-year change?
- What is 9 Meters Biopharma quarterly operating income?
- What is the all time high quarterly operating profit for 9 Meters Biopharma?
- What is 9 Meters Biopharma quarterly operating profit year-on-year change?
- What is 9 Meters Biopharma TTM operating income?
- What is the all time high TTM operating profit for 9 Meters Biopharma?
- What is 9 Meters Biopharma TTM operating profit year-on-year change?
What is 9 Meters Biopharma annual operaing income?
The current annual operating profit of NMTR is -$42.02 M
What is the all time high annual operating profit for 9 Meters Biopharma?
9 Meters Biopharma all-time high annual operaing income is -$3.37 M
What is 9 Meters Biopharma annual operating profit year-on-year change?
Over the past year, NMTR annual operaing income has changed by -$10.36 M (-32.72%)
What is 9 Meters Biopharma quarterly operating income?
The current quarterly operating profit of NMTR is -$12.79 M
What is the all time high quarterly operating profit for 9 Meters Biopharma?
9 Meters Biopharma all-time high quarterly operating income is $219.70 K
What is 9 Meters Biopharma quarterly operating profit year-on-year change?
Over the past year, NMTR quarterly operating income has changed by -$1.42 M (-12.52%)
What is 9 Meters Biopharma TTM operating income?
The current TTM operating profit of NMTR is -$43.44 M
What is the all time high TTM operating profit for 9 Meters Biopharma?
9 Meters Biopharma all-time high TTM operating income is -$1.16 M
What is 9 Meters Biopharma TTM operating profit year-on-year change?
Over the past year, NMTR TTM operating income has changed by -$5.82 M (-15.46%)